Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MODAFINIL TABLETS 100 MG — DIN 02479303

MODAFINIL : 100 MG · STRIDES PHARMA CANADA INC · TABLET · wholesale supply in Canada

Health Canada status: APPROVED

What is MODAFINIL TABLETS?

MODAFINIL TABLETS 100 MG contains MODAFINIL : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02479303, held by STRIDES PHARMA CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 12-Mar-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.

How much does Modafinil cost around the world?

Modafinil is listed on 14 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
United Statesacquisition242USD███.██
Australiaex-manufacturer77AUD███.██
SwedenAIP (pharmacy purchase price)46SEK███.██
Norwaymax AUP (pharmacy retail)15NOK███.██
Icelandmax wholesale23ISK███.██
South Africasingle exit price33ZAR███.██
AustriaKVP (Kassenverkaufspreis)12EUR███.██
Czechiamax producer price (ex-factory)12CZK███.██
United Kingdomhospital22GBP███.██
Greeceproducer price (ex-factory)22EUR███.██
Italyprezzo al pubblico (classe A)11EUR███.██
Luxembourgreimbursement11EUR███.██
Romaniamax producer price11RON███.██
Slovakiacategorised final price11EUR███.██

78 pack listings across 29 brand entries and 14 price bases, refreshed 08 Sep 2026. Ranges span every Modafinil pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Modafinil in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

8 holders have a Canadian DIN containing Modafinil, across 10 DINs, of which 7 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
TEVA CANADA LIMITED22ALERTEC, TEVA-MODAFINILSourceable in Canada
MARCAN PHARMACEUTICALS INC21IPG-MODAFINIL, MAR-MODAFINILSourceable in Canada
APOTEX INC11APO-MODAFINILSourceable in Canada
AURO PHARMA INC11AURO-MODAFINILSourceable in Canada
JAMP PHARMA CORPORATION11JAMP MODAFINILSourceable in Canada
SANIS HEALTH INC11MODAFINILSourceable in Canada
BIOMED PHARMA10BIO-MODAFINILNo marketed DIN
STRIDES PHARMA CANADA INC10MODAFINIL TABLETSNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label100 MG
Dosage formTABLET
RouteORAL

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceModafinil
ATC codeN06BA07
AHFS class28:20.80
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02479303
DIN (unpadded, as printed on some documents)2479303
Brand nameMODAFINIL TABLETS
Generic / active ingredientMODAFINIL : 100 MG
Market authorization holderSTRIDES PHARMA CANADA INC
Health Canada schedulePrescription
ATC codeN06BA07
ATC anatomical main groupN — Nervous system
ATC therapeutic subgroupN06BA
Current statusAPPROVED
Status date12-Mar-2019
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

7 of 10 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
ALERTEC100 MGTABLETTEVA CANADA LIMITEDMARKETED02239665
APO-MODAFINIL100 MGTABLETAPOTEX INCMARKETED02285398
AURO-MODAFINIL100 MGTABLETAURO PHARMA INCMARKETED02430487
JAMP MODAFINIL100 MGTABLETJAMP PHARMA CORPORATIONMARKETED02503727
MAR-MODAFINIL100 MGTABLETMARCAN PHARMACEUTICALS INCMARKETED02432560
MODAFINIL100 MGTABLETSANIS HEALTH INCMARKETED02530244
TEVA-MODAFINIL100 MGTABLETTEVA CANADA LIMITEDMARKETED02420260
BIO-MODAFINIL100 MGTABLETBIOMED PHARMACANCELLED POST MARKET02442078
IPG-MODAFINIL100 MGTABLETMARCAN PHARMACEUTICALS INCAPPROVED02432013

2 · Same class — other molecules in ATC N06BA

MoleculeCanadian brandsDINsMarketedSourceable
LisdexamfetamineAG-LISDEXAMFETAMINE · APO-LISDEXAMFETAMINE · APO-LISDEXAMFETAMINE CAPSULES · APO-LISDEXAMFETAMINE CHEWABLE TABLETS · +7 more8766Yes
AtomoxetineAG-ATOMOXETINE · APO-ATOMOXETINE · ATOMOXETINE · AURO-ATOMOXETINE · +9 more9657Yes
MethylphenidateACT METHYLPHENIDATE ER · APO-METHYLPHENIDATE · APO-METHYLPHENIDATE CR · APO-METHYLPHENIDATE ER · +25 more10355Yes
AmfetamineADDERALL XR · APO-AMPHETAMINE XR · DYANAVEL XR · PMS-AMPHETAMINES XR · +3 more4122Yes
ModafinilALERTEC · APO-MODAFINIL · AURO-MODAFINIL · BIO-MODAFINIL · +6 more107Yes
DexamfetamineAPO-DEXTROAMPHETAMINE SR · DEXEDRINE · DEXEDRINE SPANSULE · DEXTROAMPHETAMINE · +2 more96Yes
SolriamfetolSUNOSI22Yes
DexmethylphenidateATTENADE30Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC N06B

ATC subgroupMoleculesDINsMarketed
N06BCCaffeine113
N06BXIdebenone · Other Psychostimulants30

4 · Fixed-dose combinations with Canadian supply

ProductActive ingredientsHolderStatusDIN
DYANAVEL XRAMPHETAMINE (AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE), AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE) : 5 MGKYE PHARMACEUTICALS INC.MARKETED02559803

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is MODAFINIL TABLETS called?

The same molecule, Modafinil, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
ModiodalLatinIceland, Norway
AspendosLatinIceland
Modafinil OrionLatinSweden
Modafinil SandozLatinAustralia, Sweden
MyldamoLatinSweden
VIGILLatinCzechia
APO-ModafinilLatinAustralia
ModafinLatinAustralia
Modafinil GHLatinAustralia
Modafinil OrifarmLatinSweden
Modafinil ViatrisLatinAustralia
MODAFINIL-WGRLatinAustralia
ModavigilLatinAustralia

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.

Ask about availability of MODAFINIL TABLETS

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02479303. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.